Clinical trial
A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029)
NCT00127127 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00127127 |
|---|---|
| Title | A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) |
| Official title | A Phase I Clinical Study of L-001079038 in Patients With Solid Tumors |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors |
| Intervention type | Drug |
| Interventions | vorinostat |
| Enrollment | 18 |
| Start date | Jun 10, 2005 |
| Primary completion | Aug 21, 2009 |
| Completion | Aug 21, 2009 |
| First posted | Aug 5, 2005 |
| Last update posted | Sep 13, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: